EIF3A and neoplasm: Overall, our results indicate that in vitro biological activity (ADCC, inhibition of cell proliferation, down regulation of p185 Neu receptor, inhibition of ERK1/2 phosphorylation and induction of apoptosis) of rV-neuT immune sera can provide the ability of rV-neuT vaccinated mice of interfering with tumor growth in vivo.